Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020444
Filing Date
2017-10-31
Accepted
2017-10-31 06:04:22
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20170930.htm 10-Q 1461871
2 EX-31.1 sbph-ex311_8.htm EX-31.1 18464
3 EX-31.2 sbph-ex312_6.htm EX-31.2 18177
4 EX-32.1 sbph-ex321_7.htm EX-32.1 16344
  Complete submission text file 0001564590-17-020444.txt   6675515

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20170930.xml EX-101.INS 1651482
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20170930.xsd EX-101.SCH 44457
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20170930_cal.xml EX-101.CAL 44229
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20170930_def.xml EX-101.DEF 162053
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20170930_lab.xml EX-101.LAB 372934
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20170930_pre.xml EX-101.PRE 290849
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 171163942
SIC: 2834 Pharmaceutical Preparations